ISIS PHARMACEUTICALS INC's ticker is and the CUSIP is 464330909. A total of 4 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $5,917,000 | -45.1% | 146,400 | -21.9% | 0.08% | -45.7% |
| Q2 2015 | $10,785,000 | -34.6% | 187,400 | -27.6% | 0.15% | -41.7% |
| Q1 2015 | $16,491,000 | -6.4% | 259,000 | -9.2% | 0.26% | -2.6% |
| Q4 2014 | $17,614,000 | +154.0% | 285,300 | +59.7% | 0.27% | +148.6% |
| Q3 2014 | $6,935,000 | +4.9% | 178,600 | -6.9% | 0.11% | +4.9% |
| Q2 2014 | $6,611,000 | +14.7% | 191,900 | +43.9% | 0.10% | +5.2% |
| Q1 2014 | $5,764,000 | +16.5% | 133,400 | +7.4% | 0.10% | +29.3% |
| Q4 2013 | $4,948,000 | +6.2% | 124,200 | +0.1% | 0.08% | -15.7% |
| Q3 2013 | $4,659,000 | +106.9% | 124,100 | +48.1% | 0.09% | +61.8% |
| Q2 2013 | $2,252,000 | – | 83,800 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|